Our Impact 

With the launch of GBM AGILE, a new path has been uncovered—one that accelerates this pace of discovery from bench to bedside, and offers the greatest hope in the fight against cancer. Many important milestones have already been achieved, but there’s so much more on the horizon. Take a look and see how the generous support of our donors is making a difference, one dollar at a time.

Our Progress

Milestones We’ve Achieved Together

38 Trial Sites in the United States

1500 Patients  Screened

30+ Global Sites Selected

6 Pharmaceutical Partners

In addition to the progress already achieved, the AGILE trial design will make an even greater impact. The AGILE trial approach will be used to combat other rare and deadly diseases, in the near future.